Nuclear Imaging Equipment Market Size, Share, and Industry Analysis By Modality (SPECT Imaging Systems, PET Imaging Systems, and Others), By Application (Oncology, Cardiology, Neurology, and Others), By End User (Hospitals, Diagnostic Imaging Centers, and Others), and Regional Forecast, 2026-2034

The global nuclear imaging equipment market size was valued at USD 6.88 billion in 2025. The market is projected to grow from USD 7.1 billion in 2026 to USD 9.2 billion by 2034, exhibiting a CAGR of 3.29% during the forecast period.

The global nuclear imaging equipment market is rising rapidly with increasing geriatric population in the world and an increased number of age-related diseases. This population change escalates the need to have accurate diagnostic imaging, and therefore it becomes extremely essential in accurate monitoring and management of the chronic diseases.

Nuclear imaging equipment contains medical imaging equipment to visualize, diagnose, and monitor diseases based on the radiation emitted by radiotracers that are administered into the body.

• According to the U.S. Census Bureau, there were 2675 number of operational PET scanners in the U.S. in 2023.

Nuclear Imaging Equipment Market Driver

Chronic Illnesses, Imaging Innovation, and Aging Demographics to Foster the Demand for Nuclear Imaging Equipment

The rising cases of chronic diseases, which include cancer, cardiovascular, and neurological diseases, are immensely elevating the level of demand for nuclear imaging equipment. These conditions require non-invasive diagnostic measures that are accurate; hence, nuclear imaging has formed a significant segment in the modern medical world in terms of planning treatment and early diagnostic processes.

Emerging economies are increasingly investing in healthcare, with emerging markets investing in advanced imaging technologies. Improving infrastructure and policies and raising levels of patient awareness in nations like India and Brazil are offering good ground for the expansion of the market.

Nuclear Imaging Equipment Market Restraint

Policy Constraints and Talent Shortage May Affect Market Expansion

There are regulatory and reimbursement challenges that are a significant concern to the growth of the market. Equipment approval and reimbursement can be a convoluted mess coupled with spotty or non-existent reimbursement policies by region, which serves to slow down equipment adoption and introduce financial uncertainty into the decision to invest in nuclear imaging equipment by a healthcare provider.

Lack of qualified specialists are a setback to efficient utilization of nuclear imaging systems. This technology needs well-trained human resources to operate and interpret the images. Due to a shortage of skilled radiologists and technologists, accessibility is limited, and this hinders growth and development in different regions.

The risk in supply chains has a substantial impact on the nuclear imaging market because it depends on only a few radioisotope production sites. The disruption of this supply chain may lead to a delay in diagnosing and disruptive services that will negatively affect patient care and throughput of diagnostic processes.

Nuclear Imaging Equipment Market Opportunity

Digital Integration, Affordable Innovation, and Infrastructure Investment to Offer New Growth Avenues

Massive growth opportunities are being presented to the nuclear imaging equipment market by the emerging markets in Asia Pacific and Latin America, where investments in the healthcare infrastructure are on the rise. The regions have potential opportunities that might not be exploited because of the increasing population of patients, burden of disease, and demand for more advanced levels of diagnostic technology.

Nuclear imaging has a revolutionary opportunity to improve the accuracy and effectiveness of diagnosis, as well as the handling of patients, when used in combination with digital health platforms. By linking them to imaging data, electronic health records, and artificial intelligence-driven analytics, healthcare providers will have an opportunity to enhance clinical decision-making and offer more individualized treatment options.

There is a need for cost-effective nuclear imaging so as to penetrate more into the market. The innovations on affordability could also help the smaller healthcare environments and institutions in the resource-limited setting adopt the utilization of nuclear imaging technologies, expanding significantly the market size and clinical impact.

Segmentation

Key Insights

The report covers the following key insights:

• Incidence of Cancer, Neurological Disorders in Major Countries
• Advancements in PET and SPECT Diagnostics Globally
• Drivers, Emerging Technologies, and Major Investments
• Strategic Moves by Leading Players Including Mergers and Partnerships
• Regulatory Frameworks Policies Across Major Regions

Analysis by Modality

By modality, the nuclear imaging equipment market is divided into SPECT Imaging Systems, PET Imaging Systems, and others.

The SPECT Imaging Systems segment dominates the market of nuclear imaging equipment as it is less expensive, freely marketed, and utilized in a broader clinical practice in cardiology or oncology diagnosis.

The PET imaging systems segment will experience rampant growth, in no small part due to its increased application in the oncology environment to accurately locate and monitor tumours. Growth in the demand for individual treatment planning and hybrid imaging systems like PET/CT and PET/MRI is increasing diagnostic performance and market growth in this segment.

Analysis by Application

By application, the Nuclear Imaging Equipment Market is fragmented into Oncology, Cardiology, Neurology, and others.

The oncology segment captures a massive share of the nuclear imaging equipment market because of the increase in the burden of cancer cases worldwide and the consequent increase in the demand for early and proper detection of tumours. Staging and monitoring of response to treatment and recurrence using the aid of PET and SPECT are getting more and more popular, thus bringing in the segment increase. The oncology segment plays the largest role in the nuclear imaging equipment market because of the rising prevalence of cancer.

The cardiology segment is experiencing strong growth. This is due to the growing incidence of cardiovascular diseases and the soaring demand for the accurate evaluation of the perfusion and the functions of the myocardium. The latter section also grows exponentially because the nuclear imaging devices are largely applied in the diagnosis of ailments associated with coronary artery as well as in the assessment of heart performance.

Analysis by End User

Based on end user, the Nuclear Imaging Equipment market is divided into Hospitals, Diagnostic Imaging Centers, and others.

Hospitals are the largest purchasers of nuclear imaging equipment because they have the entire infrastructure, a high flow of patients, and can incorporate the latest imaging technology into clinical practices. The increased need for efficient diagnostic systems in oncology and cardiology areas further justifies the introduction of PET and SPECT systems in hospitals to help in the efficient management of the disease. The hospital segment occupies the largest portion of the nuclear imaging equipment market due to the increased flow of patients.

The diagnostic imaging centers are projected to experience moderate growth on the basis of the rising number of outpatient diagnostic procedures and growing demand for cost-efficient imaging systems. The services provided by these centers are specialized, and the wait time is less, and as nuclear imaging is getting cheaper and readily available, the services provided by these centers are becoming very important in the early detection of diseases.

Regional Analysis

To gain extensive insights into the market, Download for Customization

Based on region, the Nuclear Imaging Equipment market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America holds the largest market share due to well-developed healthcare infrastructure, a high level of acceptance of innovative technologies, and huge investments in research and development. The clinical orientation and the advanced imaging systems that the region embraced initially are contributing factors that allow the region to remain dominant in the world arena.

The Europe market will grow, owing to the well-established health care systems, supportive government policies, and the presence of major players in the production of medical devices. Focus on quality diagnostic services and support of the regulation in the region to create a steady demand for the advanced nuclear imaging technologies in multiple clinical environments.

Asia Pacific bags a considerable market share owing to the rising healthcare expenditure, the growing rate of chronic conditions, and the high status of medical tourism appeal. The development in nations like India and China is accelerating the utilization of imaging technologies due to the rise in infrastructure and the number of persons that can gain access to diagnostic processes.

Key Players Covered

The report includes the profiles of the following key players:

• GE HealthCare (U.S.)
• Siemens Healthineers AG (Germany)
• Koninklijke Philips N.V. (Netherlands)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• Mediso Ltd. (Hungary)
• Cubresa Inc. (Canada)
• Shimadzu Corporation (Japan)
• United Imaging Healthcare Co (China)

Key Industry Developments

• In August 2024, Siemens Healthineers reached an agreement to acquire a stake in Novartis Advanced Accelerator Applications business in a deal worth more than EUR 200 million. The move would add to its PET radiopharmaceutical business in Europe.